Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence



Rating:

Share or cite this content

Citations should be made in the following way:
V. Guevara Velazquez (Salamanca, Spain), C. Álvarez (Salamanca, Spain), M. Hernández Mezquita (Salamanca, Spain), J. Rauseo López (Salamanca, Spain), M. Bartol Sánchez (Salamanca, Spain), L. Gil Pintor (Salamanca, Spain), A. Sánchez Fernández (Salamanca, Spain), S. Jodra Sánchez (Salamanca, Spain), R. García García (Salamanca, Spain), M. Barrueco Ferrero (Salamanca, Spain). Sleeping disorders during nicotinic withdrawal syndrome.. 3061

Member's Comments

No comment yet.

Related content which might interest you: Sleep disorders and neuromuscular diseases: when, why and how Source: International Congress 2019 – Sleep and neuromuscular diseases: assessment and management of respiratory problems Year: 2019 Prevalence of sleep disruption and sleep disorders in patients with Post-Polio Syndrome Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Sleep disorders in Tunisian neuromuscular diseases Source: Eur Respir J 2006; 28: Suppl. 50, 197s Year: 2006 Sleep-related eating disorders: a comorbidity of sleep apnoea and restless legs syndrome Source: 5th Sleep and Breathing Conference Year: 2019 Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome Source: Eur Respir J 2001; 17: 313-315 Year: 2001 Neurocognitive disorders and sleep in primary ciliary dyskinesia children Source: International Congress 2016 – Paediatric bronchology I Year: 2016 What constituents of the metabolic syndrome are prevalent in the sleep apnoea syndrome? Source: Eur Respir J 2005; 26: Suppl. 49, 568s Year: 2005 Relationship between obstructive sleep apnoea syndrome and attention deficit hyperactivity disorder. Study in Chilean scholars Source: Eur Respir J 2003; 22: Suppl. 45, 92s Year: 2003 Moderate sleep apnoea: a “silent” disorder, or not a disorder at all? Source: Eur Respir J 2016; 47: 23-26 Year: 2016 Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007 Underlying disorders of central sleep apnoea in children Source: Sleep and Breathing Conference 2021 Year: 2021 The effect of 5-HT1A receptor on the upper airway of chronic-intermittent-hypoxia rats Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016 Behavioural and emotional disturbances associated with sleep disturbances in children with Down’s syndrome Source: Annual Congress 2013 –A paediatric palimpsest: sleep apnoea from conception to the teenage years Year: 2013 The analysis of depression symptoms in patients with sleep apnoea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 254s Year: 2001 Can sleep apnea be a secondary cause of osteoporosis in young people? Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015 Sleep-related breathing disorders: impact on mortality of cerebrovascular disease Source: Eur Respir J 2004; 24: 267-272 Year: 2004 Axonal peripheral nerve demage in obstructive sleep apnea syndrome Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016 Determination of neurotransmitters in the brain of rats with sleep apnea syndrome Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude Year: 2019 The investigation of overactive bladder symptoms in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013